RPR (US) LIMITED

Active Reading

Activities of other holding companies n.e.c.

2 employees website.com
Activities of other holding companies n.e.c.
R

RPR (US) LIMITED

Activities of other holding companies n.e.c.

Founded 24 May 1996 Active Reading, England 2 employees website.com
Activities of other holding companies n.e.c.

Previous Company Names

NOVELACROSS LIMITED 24 May 1996 — 14 Aug 1996
Accounts Submitted 12 Dec 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 5 Jan 2026 Next due 14 Jan 2027 8 months remaining
Net assets £278M £5M 2024 year on year
Total assets £278M £5M 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

410 Thames Valley Park Drive Reading Berkshire RG6 1PT England

Full company profile for RPR (US) LIMITED (03203835), an active company based in Reading, England. Incorporated 24 May 1996. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

N/A

Net Assets

£277.64M

Increased by £4.77M (+2%)

Total Liabilities

N/A

Turnover

N/A

Employees

2

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Aventisub Llc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Sanofi

France

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Feb 2026OfficersAppointment of Walaa Mostafa Abbas Awad Mohamed as director on 2026-02-01
5 Feb 2026OfficersTermination of Usman Khan as director on 2026-02-01
5 Feb 2026OfficersAppointment of Mr Ahmed Mohamed Moustafa Moussa as director on 2026-02-01
5 Feb 2026OfficersTermination of Rippondeep Ubhi as director on 2026-02-01
5 Jan 2026Confirmation StatementConfirmation statement made on 2025-12-31 with no updates
5 Feb 2026 Officers

Appointment of Walaa Mostafa Abbas Awad Mohamed as director on 2026-02-01

5 Feb 2026 Officers

Termination of Usman Khan as director on 2026-02-01

5 Feb 2026 Officers

Appointment of Mr Ahmed Mohamed Moustafa Moussa as director on 2026-02-01

5 Feb 2026 Officers

Termination of Rippondeep Ubhi as director on 2026-02-01

5 Jan 2026 Confirmation Statement

Confirmation statement made on 2025-12-31 with no updates

Recent Activity

Latest Activity

Appointment of Walaa Mostafa Abbas Awad Mohamed as director on 2026-02-01

2 months ago on 5 Feb 2026

Termination of Usman Khan as director on 2026-02-01

2 months ago on 5 Feb 2026

Appointment of Mr Ahmed Mohamed Moustafa Moussa as director on 2026-02-01

2 months ago on 5 Feb 2026

Termination of Rippondeep Ubhi as director on 2026-02-01

2 months ago on 5 Feb 2026

Confirmation statement made on 2025-12-31 with no updates

3 months ago on 5 Jan 2026